| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ... Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007 | 1730 | 2007 |
| Targeting microRNAs in cancer: rationale, strategies and challenges R Garzon, G Marcucci, CM Croce Nature reviews Drug discovery 9 (10), 775-789, 2010 | 1501 | 2010 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 945 | 2014 |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 894 | 2017 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 793 | 2009 |
| IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ... Journal of clinical oncology 28 (14), 2348, 2010 | 759 | 2010 |
| Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular … K Mrozek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield Blood 109 (2), 431-448, 2007 | 750 | 2007 |
| MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ... Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008 | 740 | 2008 |
| Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 723 | 2006 |
| Fundamentals of phase-only liquid crystal on silicon (LCOS) devices Z Zhang, Z You, D Chu Light: Science & Applications 3 (10), e213, 2014 | 667* | 2014 |
| Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications G Marcucci, T Haferlach, H Döhner Journal of Clinical Oncology 29 (5), 475-486, 2011 | 634 | 2011 |
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ... Cell 140 (5), 652-665, 2010 | 576 | 2010 |
| MicroRNA fingerprints during human megakaryocytopoiesis R Garzon, F Pichiorri, T Palumbo, R Iuliano, A Cimmino, R Aqeilan, ... Proceedings of the National Academy of Sciences 103 (13), 5078-5083, 2006 | 552 | 2006 |
| The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ... Cancer cell 8 (5), 355-368, 2005 | 528 | 2005 |
| Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine W Blum, R Garzon, RB Klisovic, S Schwind, A Walker, S Geyer, S Liu, ... Proceedings of the National Academy of Sciences 107 (16), 7473-7478, 2010 | 518 | 2010 |
| MicroRNA expression in cytogenetically normal acute myeloid leukemia G Marcucci, MD Radmacher, K Maharry, K Mrózek, AS Ruppert, ... New England Journal of Medicine 358 (18), 1919-1928, 2008 | 491 | 2008 |
| MicroRNA 29b functions in acute myeloid leukemia R Garzon, CEA Heaphy, V Havelange, M Fabbri, S Volinia, T Tsao, ... Blood 114 (26), 5331-5341, 2009 | 475 | 2009 |
| A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic, M Moran, TS Lin, ... Blood 105 (3), 959-967, 2005 | 456 | 2005 |
| Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia K Mrózek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ... Journal of clinical oncology 30 (36), 4515, 2012 | 414 | 2012 |
| Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study V Goede, K Fischer, A Engelke, R Schlag, S Lepretre, LFC Montero, ... Leukemia 29 (7), 1602-1604, 2015 | 412* | 2015 |
Shujun LiuProfessor, University of MinnesotaVerified email at hi.umn.edu
